Project
Inflammatory response time course, HUVEC (Wada et al., 2009)
Navigation
Downloads
Results for MYF6
Z-value: 1.44
Motif logo
Transcription factors associated with MYF6
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
MYF6
|
ENSG00000111046.3 | myogenic factor 6 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| MYF6 | hg19_v2_chr12_+_81101277_81101321 | -0.01 | 9.5e-01 | Click! |
Activity profile of MYF6 motif
Sorted Z-values of MYF6 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr13_-_72440901 | 15.98 |
ENST00000359684.2
|
DACH1
|
dachshund homolog 1 (Drosophila) |
| chr17_+_39382900 | 13.10 |
ENST00000377721.3
ENST00000455970.2 |
KRTAP9-2
|
keratin associated protein 9-2 |
| chr11_+_71238313 | 8.55 |
ENST00000398536.4
|
KRTAP5-7
|
keratin associated protein 5-7 |
| chr7_-_11871815 | 7.32 |
ENST00000423059.4
|
THSD7A
|
thrombospondin, type I, domain containing 7A |
| chr2_+_148778570 | 6.45 |
ENST00000407073.1
|
MBD5
|
methyl-CpG binding domain protein 5 |
| chr18_-_53253323 | 5.14 |
ENST00000540999.1
ENST00000563888.2 |
TCF4
|
transcription factor 4 |
| chr18_-_53253112 | 4.89 |
ENST00000568673.1
ENST00000562847.1 ENST00000568147.1 |
TCF4
|
transcription factor 4 |
| chr14_-_54423529 | 4.69 |
ENST00000245451.4
ENST00000559087.1 |
BMP4
|
bone morphogenetic protein 4 |
| chr4_+_41540160 | 4.29 |
ENST00000503057.1
ENST00000511496.1 |
LIMCH1
|
LIM and calponin homology domains 1 |
| chr3_+_32280159 | 4.14 |
ENST00000458535.2
ENST00000307526.3 |
CMTM8
|
CKLF-like MARVEL transmembrane domain containing 8 |
| chr1_-_92351769 | 3.97 |
ENST00000212355.4
|
TGFBR3
|
transforming growth factor, beta receptor III |
| chr14_+_24867992 | 3.90 |
ENST00000382554.3
|
NYNRIN
|
NYN domain and retroviral integrase containing |
| chr17_+_68165657 | 3.86 |
ENST00000243457.3
|
KCNJ2
|
potassium inwardly-rectifying channel, subfamily J, member 2 |
| chr17_+_39394250 | 3.78 |
ENST00000254072.6
|
KRTAP9-8
|
keratin associated protein 9-8 |
| chr11_-_33913708 | 3.68 |
ENST00000257818.2
|
LMO2
|
LIM domain only 2 (rhombotin-like 1) |
| chr7_-_27183263 | 3.59 |
ENST00000222726.3
|
HOXA5
|
homeobox A5 |
| chr12_-_76425368 | 3.57 |
ENST00000602540.1
|
PHLDA1
|
pleckstrin homology-like domain, family A, member 1 |
| chr3_-_124774802 | 3.47 |
ENST00000311127.4
|
HEG1
|
heart development protein with EGF-like domains 1 |
| chrX_-_119694538 | 3.32 |
ENST00000371322.5
|
CUL4B
|
cullin 4B |
| chr12_+_20522179 | 3.30 |
ENST00000359062.3
|
PDE3A
|
phosphodiesterase 3A, cGMP-inhibited |
| chr16_-_30107491 | 3.19 |
ENST00000566134.1
ENST00000565110.1 ENST00000398841.1 ENST00000398838.4 |
YPEL3
|
yippee-like 3 (Drosophila) |
| chrX_-_135849484 | 3.14 |
ENST00000370620.1
ENST00000535227.1 |
ARHGEF6
|
Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6 |
| chr18_-_22932080 | 3.01 |
ENST00000584787.1
ENST00000361524.3 ENST00000538137.2 |
ZNF521
|
zinc finger protein 521 |
| chr1_+_87797351 | 2.99 |
ENST00000370542.1
|
LMO4
|
LIM domain only 4 |
| chr6_+_136172820 | 2.90 |
ENST00000308191.6
|
PDE7B
|
phosphodiesterase 7B |
| chr2_-_74667612 | 2.90 |
ENST00000305557.5
ENST00000233330.6 |
RTKN
|
rhotekin |
| chr14_-_54421190 | 2.88 |
ENST00000417573.1
|
BMP4
|
bone morphogenetic protein 4 |
| chr6_-_76203345 | 2.88 |
ENST00000393004.2
|
FILIP1
|
filamin A interacting protein 1 |
| chr10_-_64576105 | 2.83 |
ENST00000242480.3
ENST00000411732.1 |
EGR2
|
early growth response 2 |
| chr15_+_96873921 | 2.80 |
ENST00000394166.3
|
NR2F2
|
nuclear receptor subfamily 2, group F, member 2 |
| chr1_-_231114542 | 2.78 |
ENST00000522821.1
ENST00000366661.4 ENST00000366662.4 ENST00000414259.1 ENST00000522399.1 |
TTC13
|
tetratricopeptide repeat domain 13 |
| chr2_+_191745535 | 2.74 |
ENST00000320717.3
|
GLS
|
glutaminase |
| chr6_-_32191834 | 2.67 |
ENST00000375023.3
|
NOTCH4
|
notch 4 |
| chr13_+_36050881 | 2.66 |
ENST00000537702.1
|
NBEA
|
neurobeachin |
| chr4_-_102268484 | 2.52 |
ENST00000394853.4
|
PPP3CA
|
protein phosphatase 3, catalytic subunit, alpha isozyme |
| chr8_-_80993010 | 2.49 |
ENST00000537855.1
ENST00000520527.1 ENST00000517427.1 ENST00000448733.2 ENST00000379097.3 |
TPD52
|
tumor protein D52 |
| chr1_+_153747746 | 2.48 |
ENST00000368661.3
|
SLC27A3
|
solute carrier family 27 (fatty acid transporter), member 3 |
| chr13_+_31480328 | 2.47 |
ENST00000380482.4
|
MEDAG
|
mesenteric estrogen-dependent adipogenesis |
| chr21_-_46012386 | 2.43 |
ENST00000400368.1
|
KRTAP10-6
|
keratin associated protein 10-6 |
| chr6_-_150185156 | 2.38 |
ENST00000239367.2
ENST00000367368.2 |
LRP11
|
low density lipoprotein receptor-related protein 11 |
| chr5_+_148960931 | 2.37 |
ENST00000333677.6
|
ARHGEF37
|
Rho guanine nucleotide exchange factor (GEF) 37 |
| chr1_+_77997785 | 2.37 |
ENST00000478255.1
|
AK5
|
adenylate kinase 5 |
| chr6_-_76203454 | 2.33 |
ENST00000237172.7
|
FILIP1
|
filamin A interacting protein 1 |
| chr1_+_78354297 | 2.31 |
ENST00000334785.7
|
NEXN
|
nexilin (F actin binding protein) |
| chr3_+_110790590 | 2.24 |
ENST00000485303.1
|
PVRL3
|
poliovirus receptor-related 3 |
| chr8_-_89339705 | 2.24 |
ENST00000286614.6
|
MMP16
|
matrix metallopeptidase 16 (membrane-inserted) |
| chrX_+_86772787 | 2.23 |
ENST00000373114.4
|
KLHL4
|
kelch-like family member 4 |
| chr11_-_33891362 | 2.18 |
ENST00000395833.3
|
LMO2
|
LIM domain only 2 (rhombotin-like 1) |
| chrX_+_46433193 | 2.12 |
ENST00000276055.3
|
CHST7
|
carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 7 |
| chr3_+_32147997 | 2.12 |
ENST00000282541.5
|
GPD1L
|
glycerol-3-phosphate dehydrogenase 1-like |
| chr20_+_33759854 | 2.08 |
ENST00000216968.4
|
PROCR
|
protein C receptor, endothelial |
| chr11_-_66115032 | 2.07 |
ENST00000311181.4
|
B3GNT1
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1 |
| chr2_-_220083076 | 2.06 |
ENST00000295750.4
|
ABCB6
|
ATP-binding cassette, sub-family B (MDR/TAP), member 6 |
| chr4_-_103682071 | 2.01 |
ENST00000505239.1
|
MANBA
|
mannosidase, beta A, lysosomal |
| chr4_-_149365827 | 1.98 |
ENST00000344721.4
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2 |
| chr12_-_95044309 | 1.97 |
ENST00000261226.4
|
TMCC3
|
transmembrane and coiled-coil domain family 3 |
| chr2_-_220435963 | 1.97 |
ENST00000373876.1
ENST00000404537.1 ENST00000603926.1 ENST00000373873.4 ENST00000289656.3 |
OBSL1
|
obscurin-like 1 |
| chr1_+_78354175 | 1.96 |
ENST00000401035.3
ENST00000457030.1 ENST00000330010.8 |
NEXN
|
nexilin (F actin binding protein) |
| chrX_+_73641286 | 1.96 |
ENST00000587091.1
|
SLC16A2
|
solute carrier family 16, member 2 (thyroid hormone transporter) |
| chr16_-_88772670 | 1.90 |
ENST00000562544.1
|
RNF166
|
ring finger protein 166 |
| chr4_+_6271558 | 1.90 |
ENST00000503569.1
ENST00000226760.1 |
WFS1
|
Wolfram syndrome 1 (wolframin) |
| chr5_+_137801160 | 1.89 |
ENST00000239938.4
|
EGR1
|
early growth response 1 |
| chr5_-_88179302 | 1.88 |
ENST00000504921.2
|
MEF2C
|
myocyte enhancer factor 2C |
| chr1_+_231114795 | 1.83 |
ENST00000310256.2
ENST00000366658.2 ENST00000450711.1 ENST00000435927.1 |
ARV1
|
ARV1 homolog (S. cerevisiae) |
| chr16_-_88772761 | 1.82 |
ENST00000567844.1
ENST00000312838.4 |
RNF166
|
ring finger protein 166 |
| chr13_-_28194541 | 1.82 |
ENST00000316334.3
|
LNX2
|
ligand of numb-protein X 2 |
| chr9_-_124989804 | 1.81 |
ENST00000373755.2
ENST00000373754.2 |
LHX6
|
LIM homeobox 6 |
| chr12_-_12503156 | 1.81 |
ENST00000543314.1
ENST00000396349.3 |
MANSC1
|
MANSC domain containing 1 |
| chr6_+_157099036 | 1.78 |
ENST00000350026.5
ENST00000346085.5 ENST00000367148.1 ENST00000275248.4 |
ARID1B
|
AT rich interactive domain 1B (SWI1-like) |
| chr7_+_94023873 | 1.78 |
ENST00000297268.6
|
COL1A2
|
collagen, type I, alpha 2 |
| chrX_+_86772707 | 1.76 |
ENST00000373119.4
|
KLHL4
|
kelch-like family member 4 |
| chr14_+_58765103 | 1.71 |
ENST00000355431.3
ENST00000348476.3 ENST00000395168.3 |
ARID4A
|
AT rich interactive domain 4A (RBP1-like) |
| chr5_-_107717058 | 1.70 |
ENST00000359660.5
|
FBXL17
|
F-box and leucine-rich repeat protein 17 |
| chr19_-_19051103 | 1.69 |
ENST00000542541.2
ENST00000433218.2 |
HOMER3
|
homer homolog 3 (Drosophila) |
| chr2_+_112656176 | 1.68 |
ENST00000421804.2
ENST00000409780.1 |
MERTK
|
c-mer proto-oncogene tyrosine kinase |
| chr20_+_37434329 | 1.65 |
ENST00000299824.1
ENST00000373331.2 |
PPP1R16B
|
protein phosphatase 1, regulatory subunit 16B |
| chr6_+_123110465 | 1.62 |
ENST00000539041.1
|
SMPDL3A
|
sphingomyelin phosphodiesterase, acid-like 3A |
| chr4_+_87928140 | 1.61 |
ENST00000307808.6
|
AFF1
|
AF4/FMR2 family, member 1 |
| chr16_+_55542910 | 1.60 |
ENST00000262134.5
|
LPCAT2
|
lysophosphatidylcholine acyltransferase 2 |
| chr5_+_42423872 | 1.60 |
ENST00000230882.4
ENST00000357703.3 |
GHR
|
growth hormone receptor |
| chr4_-_141075330 | 1.59 |
ENST00000509479.2
|
MAML3
|
mastermind-like 3 (Drosophila) |
| chr11_+_1718425 | 1.58 |
ENST00000382160.1
|
KRTAP5-6
|
keratin associated protein 5-6 |
| chr17_+_42634844 | 1.57 |
ENST00000315323.3
|
FZD2
|
frizzled family receptor 2 |
| chr11_+_68080077 | 1.57 |
ENST00000294304.7
|
LRP5
|
low density lipoprotein receptor-related protein 5 |
| chr6_+_123110302 | 1.57 |
ENST00000368440.4
|
SMPDL3A
|
sphingomyelin phosphodiesterase, acid-like 3A |
| chr22_+_19705928 | 1.55 |
ENST00000383045.3
ENST00000438754.2 |
SEPT5
|
septin 5 |
| chr4_+_102268904 | 1.55 |
ENST00000527564.1
ENST00000529296.1 |
AP001816.1
|
Uncharacterized protein |
| chr17_-_39968855 | 1.49 |
ENST00000355468.3
ENST00000590496.1 |
LEPREL4
|
leprecan-like 4 |
| chr3_-_58196939 | 1.49 |
ENST00000394549.2
ENST00000461914.3 |
DNASE1L3
|
deoxyribonuclease I-like 3 |
| chr9_-_139581848 | 1.49 |
ENST00000538402.1
ENST00000371694.3 |
AGPAT2
|
1-acylglycerol-3-phosphate O-acyltransferase 2 |
| chr9_+_141107506 | 1.48 |
ENST00000446912.2
|
FAM157B
|
family with sequence similarity 157, member B |
| chr8_+_37654424 | 1.48 |
ENST00000315215.7
|
GPR124
|
G protein-coupled receptor 124 |
| chr13_-_110438914 | 1.48 |
ENST00000375856.3
|
IRS2
|
insulin receptor substrate 2 |
| chrX_+_100333709 | 1.46 |
ENST00000372930.4
|
TMEM35
|
transmembrane protein 35 |
| chr4_-_103682145 | 1.46 |
ENST00000226578.4
|
MANBA
|
mannosidase, beta A, lysosomal |
| chr3_+_124303472 | 1.45 |
ENST00000291478.5
|
KALRN
|
kalirin, RhoGEF kinase |
| chr12_-_118541743 | 1.45 |
ENST00000359236.5
|
VSIG10
|
V-set and immunoglobulin domain containing 10 |
| chr7_+_102553430 | 1.44 |
ENST00000339431.4
ENST00000249377.4 |
LRRC17
|
leucine rich repeat containing 17 |
| chr18_-_72920372 | 1.44 |
ENST00000581620.1
ENST00000582437.1 |
ZADH2
|
zinc binding alcohol dehydrogenase domain containing 2 |
| chr20_+_2673383 | 1.44 |
ENST00000380648.4
ENST00000342725.5 |
EBF4
|
early B-cell factor 4 |
| chr2_+_203499901 | 1.43 |
ENST00000303116.6
ENST00000392238.2 |
FAM117B
|
family with sequence similarity 117, member B |
| chr14_-_105635090 | 1.43 |
ENST00000331782.3
ENST00000347004.2 |
JAG2
|
jagged 2 |
| chr16_+_30406721 | 1.41 |
ENST00000320159.2
|
ZNF48
|
zinc finger protein 48 |
| chr9_-_139581875 | 1.41 |
ENST00000371696.2
|
AGPAT2
|
1-acylglycerol-3-phosphate O-acyltransferase 2 |
| chr2_+_136289030 | 1.40 |
ENST00000409478.1
ENST00000264160.4 ENST00000329971.3 ENST00000438014.1 |
R3HDM1
|
R3H domain containing 1 |
| chr11_-_31531121 | 1.39 |
ENST00000532287.1
ENST00000526776.1 ENST00000534812.1 ENST00000529749.1 ENST00000278200.1 ENST00000530023.1 ENST00000533642.1 |
IMMP1L
|
IMP1 inner mitochondrial membrane peptidase-like (S. cerevisiae) |
| chr6_+_7727030 | 1.39 |
ENST00000283147.6
|
BMP6
|
bone morphogenetic protein 6 |
| chr13_-_108518986 | 1.38 |
ENST00000375915.2
|
FAM155A
|
family with sequence similarity 155, member A |
| chr16_+_53133070 | 1.38 |
ENST00000565832.1
|
CHD9
|
chromodomain helicase DNA binding protein 9 |
| chrX_+_118108601 | 1.37 |
ENST00000371628.3
|
LONRF3
|
LON peptidase N-terminal domain and ring finger 3 |
| chr9_-_13165457 | 1.36 |
ENST00000542239.1
ENST00000538841.1 ENST00000433359.2 |
MPDZ
|
multiple PDZ domain protein |
| chr10_+_99079008 | 1.36 |
ENST00000371021.3
|
FRAT1
|
frequently rearranged in advanced T-cell lymphomas |
| chr14_+_100150622 | 1.34 |
ENST00000261835.3
|
CYP46A1
|
cytochrome P450, family 46, subfamily A, polypeptide 1 |
| chr6_-_28321971 | 1.33 |
ENST00000396838.2
ENST00000426434.1 ENST00000434036.1 ENST00000439628.1 |
ZSCAN31
|
zinc finger and SCAN domain containing 31 |
| chr12_-_6665200 | 1.32 |
ENST00000336604.4
ENST00000396840.2 ENST00000356896.4 |
IFFO1
|
intermediate filament family orphan 1 |
| chr7_+_86975001 | 1.32 |
ENST00000412227.2
ENST00000331536.3 |
CROT
|
carnitine O-octanoyltransferase |
| chr4_-_101111615 | 1.31 |
ENST00000273990.2
|
DDIT4L
|
DNA-damage-inducible transcript 4-like |
| chr10_-_18948156 | 1.31 |
ENST00000414939.1
ENST00000449529.1 ENST00000456217.1 ENST00000444660.1 |
ARL5B-AS1
|
ARL5B antisense RNA 1 |
| chr10_-_102089729 | 1.30 |
ENST00000465680.2
|
PKD2L1
|
polycystic kidney disease 2-like 1 |
| chr19_-_2042065 | 1.30 |
ENST00000591588.1
ENST00000591142.1 |
MKNK2
|
MAP kinase interacting serine/threonine kinase 2 |
| chr12_+_56521840 | 1.30 |
ENST00000394048.5
|
ESYT1
|
extended synaptotagmin-like protein 1 |
| chr20_-_23066953 | 1.29 |
ENST00000246006.4
|
CD93
|
CD93 molecule |
| chr12_+_79258444 | 1.28 |
ENST00000261205.4
|
SYT1
|
synaptotagmin I |
| chr22_-_37882395 | 1.28 |
ENST00000416983.3
ENST00000424765.2 ENST00000356998.3 |
MFNG
|
MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
| chr16_-_4850471 | 1.27 |
ENST00000592019.1
ENST00000586153.1 |
ROGDI
|
rogdi homolog (Drosophila) |
| chr6_-_111804393 | 1.27 |
ENST00000368802.3
ENST00000368805.1 |
REV3L
|
REV3-like, polymerase (DNA directed), zeta, catalytic subunit |
| chr1_-_236228417 | 1.27 |
ENST00000264187.6
|
NID1
|
nidogen 1 |
| chr3_-_18466787 | 1.27 |
ENST00000338745.6
ENST00000450898.1 |
SATB1
|
SATB homeobox 1 |
| chr14_-_92414055 | 1.27 |
ENST00000342058.4
|
FBLN5
|
fibulin 5 |
| chr3_-_58196688 | 1.26 |
ENST00000486455.1
|
DNASE1L3
|
deoxyribonuclease I-like 3 |
| chr11_-_65325664 | 1.26 |
ENST00000301873.5
|
LTBP3
|
latent transforming growth factor beta binding protein 3 |
| chr13_+_114567131 | 1.25 |
ENST00000608651.1
|
GAS6-AS2
|
GAS6 antisense RNA 2 (head to head) |
| chr9_-_80646374 | 1.25 |
ENST00000286548.4
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide |
| chr1_-_236228403 | 1.25 |
ENST00000366595.3
|
NID1
|
nidogen 1 |
| chrX_+_118108571 | 1.24 |
ENST00000304778.7
|
LONRF3
|
LON peptidase N-terminal domain and ring finger 3 |
| chr11_+_22688150 | 1.24 |
ENST00000454584.2
|
GAS2
|
growth arrest-specific 2 |
| chr6_+_30851840 | 1.24 |
ENST00000511510.1
ENST00000376569.3 ENST00000376575.3 ENST00000376570.4 ENST00000446312.1 ENST00000504927.1 |
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
| chr15_+_96875657 | 1.24 |
ENST00000559679.1
ENST00000394171.2 |
NR2F2
|
nuclear receptor subfamily 2, group F, member 2 |
| chr10_+_94594351 | 1.21 |
ENST00000371552.4
|
EXOC6
|
exocyst complex component 6 |
| chr20_-_57582296 | 1.20 |
ENST00000217131.5
|
CTSZ
|
cathepsin Z |
| chr14_-_23288930 | 1.20 |
ENST00000554517.1
ENST00000285850.7 ENST00000397529.2 ENST00000555702.1 |
SLC7A7
|
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
| chr14_-_24977457 | 1.20 |
ENST00000250378.3
ENST00000206446.4 |
CMA1
|
chymase 1, mast cell |
| chr20_+_1246908 | 1.19 |
ENST00000381873.3
ENST00000381867.1 |
SNPH
|
syntaphilin |
| chr12_+_79258547 | 1.19 |
ENST00000457153.2
|
SYT1
|
synaptotagmin I |
| chr4_-_39640513 | 1.18 |
ENST00000511809.1
ENST00000505729.1 |
SMIM14
|
small integral membrane protein 14 |
| chr16_-_31214051 | 1.17 |
ENST00000350605.4
|
PYCARD
|
PYD and CARD domain containing |
| chr12_-_104443890 | 1.16 |
ENST00000547583.1
ENST00000360814.4 ENST00000546851.1 |
GLT8D2
|
glycosyltransferase 8 domain containing 2 |
| chr7_+_2559399 | 1.16 |
ENST00000222725.5
ENST00000359574.3 |
LFNG
|
LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
| chr12_+_125478241 | 1.16 |
ENST00000341446.8
|
BRI3BP
|
BRI3 binding protein |
| chr11_-_65325430 | 1.12 |
ENST00000322147.4
|
LTBP3
|
latent transforming growth factor beta binding protein 3 |
| chrX_-_54522558 | 1.12 |
ENST00000375135.3
|
FGD1
|
FYVE, RhoGEF and PH domain containing 1 |
| chr21_+_17791648 | 1.12 |
ENST00000602892.1
ENST00000418813.2 ENST00000435697.1 |
LINC00478
|
long intergenic non-protein coding RNA 478 |
| chr9_-_20622478 | 1.11 |
ENST00000355930.6
ENST00000380338.4 |
MLLT3
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3 |
| chr11_-_82782861 | 1.11 |
ENST00000524635.1
ENST00000526205.1 ENST00000527633.1 ENST00000533486.1 ENST00000533276.2 |
RAB30
|
RAB30, member RAS oncogene family |
| chr6_+_18387570 | 1.11 |
ENST00000259939.3
|
RNF144B
|
ring finger protein 144B |
| chr19_+_48216600 | 1.10 |
ENST00000263277.3
ENST00000538399.1 |
EHD2
|
EH-domain containing 2 |
| chr1_+_110754094 | 1.10 |
ENST00000369787.3
ENST00000413138.3 ENST00000438661.2 |
KCNC4
|
potassium voltage-gated channel, Shaw-related subfamily, member 4 |
| chr11_-_14913765 | 1.08 |
ENST00000334636.5
|
CYP2R1
|
cytochrome P450, family 2, subfamily R, polypeptide 1 |
| chr12_-_71003568 | 1.07 |
ENST00000547715.1
ENST00000451516.2 ENST00000538708.1 ENST00000550857.1 ENST00000261266.5 |
PTPRB
|
protein tyrosine phosphatase, receptor type, B |
| chr11_+_31531291 | 1.07 |
ENST00000350638.5
ENST00000379163.5 ENST00000395934.2 |
ELP4
|
elongator acetyltransferase complex subunit 4 |
| chr2_+_189156721 | 1.06 |
ENST00000409927.1
ENST00000409805.1 |
GULP1
|
GULP, engulfment adaptor PTB domain containing 1 |
| chr2_-_220408430 | 1.06 |
ENST00000243776.6
|
CHPF
|
chondroitin polymerizing factor |
| chr6_-_110500905 | 1.06 |
ENST00000392587.2
|
WASF1
|
WAS protein family, member 1 |
| chr19_+_18111927 | 1.05 |
ENST00000379656.3
|
ARRDC2
|
arrestin domain containing 2 |
| chr7_-_132262060 | 1.05 |
ENST00000359827.3
|
PLXNA4
|
plexin A4 |
| chr21_+_17791838 | 1.05 |
ENST00000453910.1
|
LINC00478
|
long intergenic non-protein coding RNA 478 |
| chr1_-_21503337 | 1.05 |
ENST00000400422.1
ENST00000602326.1 ENST00000411888.1 ENST00000438975.1 |
EIF4G3
|
eukaryotic translation initiation factor 4 gamma, 3 |
| chr2_+_11295624 | 1.04 |
ENST00000402361.1
ENST00000428481.1 |
PQLC3
|
PQ loop repeat containing 3 |
| chr14_-_75422280 | 1.03 |
ENST00000238607.6
ENST00000553716.1 |
PGF
|
placental growth factor |
| chr17_-_47755436 | 1.03 |
ENST00000505581.1
ENST00000514121.1 ENST00000393328.2 ENST00000509079.1 ENST00000393331.3 ENST00000347630.2 ENST00000504102.1 |
SPOP
|
speckle-type POZ protein |
| chr2_-_220436248 | 1.02 |
ENST00000265318.4
|
OBSL1
|
obscurin-like 1 |
| chr18_+_6834472 | 1.02 |
ENST00000581099.1
ENST00000419673.2 ENST00000531294.1 |
ARHGAP28
|
Rho GTPase activating protein 28 |
| chr11_-_1643368 | 1.02 |
ENST00000399682.1
|
KRTAP5-4
|
keratin associated protein 5-4 |
| chr3_-_194991876 | 1.02 |
ENST00000310380.6
|
XXYLT1
|
xyloside xylosyltransferase 1 |
| chr17_+_72744791 | 1.01 |
ENST00000583369.1
ENST00000262613.5 |
SLC9A3R1
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1 |
| chr14_-_78083112 | 1.00 |
ENST00000216484.2
|
SPTLC2
|
serine palmitoyltransferase, long chain base subunit 2 |
| chr6_-_31830655 | 1.00 |
ENST00000375631.4
|
NEU1
|
sialidase 1 (lysosomal sialidase) |
| chr14_+_75230011 | 1.00 |
ENST00000552421.1
ENST00000325680.7 ENST00000238571.3 |
YLPM1
|
YLP motif containing 1 |
| chr3_-_69062764 | 0.99 |
ENST00000295571.5
|
EOGT
|
EGF domain-specific O-linked N-acetylglucosamine (GlcNAc) transferase |
| chr12_+_52445191 | 0.99 |
ENST00000243050.1
ENST00000394825.1 ENST00000550763.1 ENST00000394824.2 ENST00000548232.1 ENST00000562373.1 |
NR4A1
|
nuclear receptor subfamily 4, group A, member 1 |
| chr12_-_125348329 | 0.99 |
ENST00000546215.1
ENST00000415380.2 ENST00000261693.6 ENST00000376788.1 ENST00000545493.1 |
SCARB1
|
scavenger receptor class B, member 1 |
| chr12_+_9144626 | 0.99 |
ENST00000543895.1
|
KLRG1
|
killer cell lectin-like receptor subfamily G, member 1 |
| chr3_+_107318157 | 0.98 |
ENST00000406780.1
|
BBX
|
bobby sox homolog (Drosophila) |
| chr19_-_53193731 | 0.98 |
ENST00000598536.1
ENST00000594682.2 ENST00000601257.1 |
ZNF83
|
zinc finger protein 83 |
| chr9_-_101558777 | 0.97 |
ENST00000375018.1
ENST00000353234.4 |
ANKS6
|
ankyrin repeat and sterile alpha motif domain containing 6 |
| chr2_-_152118352 | 0.97 |
ENST00000331426.5
|
RBM43
|
RNA binding motif protein 43 |
| chr12_-_52585765 | 0.96 |
ENST00000313234.5
ENST00000394815.2 |
KRT80
|
keratin 80 |
| chr3_-_105587879 | 0.95 |
ENST00000264122.4
ENST00000403724.1 ENST00000405772.1 |
CBLB
|
Cbl proto-oncogene B, E3 ubiquitin protein ligase |
| chr4_-_54232144 | 0.95 |
ENST00000388940.4
ENST00000503450.1 ENST00000401642.3 |
SCFD2
|
sec1 family domain containing 2 |
| chr15_+_41221536 | 0.94 |
ENST00000249749.5
|
DLL4
|
delta-like 4 (Drosophila) |
| chr6_+_32006042 | 0.93 |
ENST00000418967.2
|
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2 |
| chr7_+_128828713 | 0.93 |
ENST00000249373.3
|
SMO
|
smoothened, frizzled family receptor |
| chr2_+_217498105 | 0.92 |
ENST00000233809.4
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa |
| chr5_+_140213815 | 0.92 |
ENST00000525929.1
ENST00000378125.3 |
PCDHA7
|
protocadherin alpha 7 |
| chr10_+_129845823 | 0.92 |
ENST00000306042.5
|
PTPRE
|
protein tyrosine phosphatase, receptor type, E |
| chr11_+_47270475 | 0.91 |
ENST00000481889.2
ENST00000436778.1 ENST00000531660.1 ENST00000407404.1 |
NR1H3
|
nuclear receptor subfamily 1, group H, member 3 |
| chr1_-_109940550 | 0.91 |
ENST00000256637.6
|
SORT1
|
sortilin 1 |
| chr9_-_5833027 | 0.91 |
ENST00000339450.5
|
ERMP1
|
endoplasmic reticulum metallopeptidase 1 |
| chr9_-_129884902 | 0.91 |
ENST00000373417.1
|
ANGPTL2
|
angiopoietin-like 2 |
| chr17_+_7758374 | 0.91 |
ENST00000301599.6
ENST00000574668.1 |
TMEM88
|
transmembrane protein 88 |
Network of associatons between targets according to the STRING database.
First level regulatory network of MYF6
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.5 | 7.6 | GO:0048391 | apoptotic process involved in endocardial cushion morphogenesis(GO:0003277) intermediate mesoderm morphogenesis(GO:0048390) intermediate mesoderm formation(GO:0048391) intermediate mesodermal cell differentiation(GO:0048392) regulation of cardiac muscle fiber development(GO:0055018) positive regulation of cardiac muscle fiber development(GO:0055020) bud dilation involved in lung branching(GO:0060503) BMP signaling pathway involved in ureter morphogenesis(GO:0061149) renal system segmentation(GO:0061150) BMP signaling pathway involved in renal system segmentation(GO:0061151) pulmonary artery endothelial tube morphogenesis(GO:0061155) regulation of transcription from RNA polymerase II promoter involved in mesonephros development(GO:0061216) BMP signaling pathway involved in nephric duct formation(GO:0071893) negative regulation of branch elongation involved in ureteric bud branching(GO:0072096) negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway(GO:0072097) anterior/posterior pattern specification involved in ureteric bud development(GO:0072099) specification of ureteric bud anterior/posterior symmetry(GO:0072100) specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway(GO:0072101) ureter epithelial cell differentiation(GO:0072192) negative regulation of mesenchymal cell proliferation involved in ureter development(GO:0072200) positive regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901964) cardiac jelly development(GO:1905072) regulation of metanephric S-shaped body morphogenesis(GO:2000004) negative regulation of metanephric S-shaped body morphogenesis(GO:2000005) regulation of metanephric comma-shaped body morphogenesis(GO:2000006) negative regulation of metanephric comma-shaped body morphogenesis(GO:2000007) |
| 2.0 | 16.2 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 1.2 | 3.6 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
| 1.2 | 3.5 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
| 1.0 | 3.1 | GO:0060435 | bronchiole development(GO:0060435) |
| 1.0 | 3.1 | GO:0050720 | interleukin-1 beta biosynthetic process(GO:0050720) |
| 1.0 | 6.1 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 1.0 | 4.0 | GO:0009956 | radial pattern formation(GO:0009956) |
| 1.0 | 4.0 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
| 1.0 | 3.9 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
| 0.9 | 2.8 | GO:0035284 | rhombomere 3 development(GO:0021569) rhombomere 5 development(GO:0021571) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 0.9 | 0.9 | GO:0072554 | blood vessel lumenization(GO:0072554) |
| 0.8 | 2.5 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
| 0.8 | 2.5 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 0.8 | 2.5 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 0.8 | 3.0 | GO:1902460 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.6 | 3.1 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 0.6 | 2.4 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 0.6 | 2.4 | GO:0006172 | ADP biosynthetic process(GO:0006172) purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) |
| 0.6 | 1.7 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
| 0.6 | 3.3 | GO:0071321 | cellular response to cGMP(GO:0071321) |
| 0.5 | 1.6 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.5 | 2.0 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
| 0.5 | 2.9 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
| 0.5 | 1.4 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.5 | 4.3 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.5 | 1.9 | GO:0003138 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
| 0.4 | 1.8 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
| 0.4 | 1.7 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
| 0.4 | 0.4 | GO:0035802 | adrenal cortex development(GO:0035801) adrenal cortex formation(GO:0035802) |
| 0.4 | 1.6 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
| 0.4 | 1.6 | GO:0000255 | allantoin metabolic process(GO:0000255) |
| 0.4 | 0.8 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.4 | 1.6 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
| 0.4 | 2.7 | GO:0048539 | bone marrow development(GO:0048539) |
| 0.4 | 1.2 | GO:0002585 | myeloid dendritic cell activation involved in immune response(GO:0002277) positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 0.4 | 1.1 | GO:0021793 | chemorepulsion of branchiomotor axon(GO:0021793) |
| 0.3 | 1.0 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
| 0.3 | 2.0 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.3 | 1.0 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
| 0.3 | 0.3 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
| 0.3 | 3.9 | GO:0015074 | DNA integration(GO:0015074) |
| 0.3 | 0.3 | GO:0071226 | response to molecule of fungal origin(GO:0002238) cellular response to molecule of fungal origin(GO:0071226) |
| 0.3 | 1.2 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
| 0.3 | 2.0 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
| 0.3 | 1.4 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
| 0.3 | 0.8 | GO:0072720 | cellular response to mycotoxin(GO:0036146) response to dithiothreitol(GO:0072720) |
| 0.3 | 4.9 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
| 0.3 | 0.8 | GO:1903989 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) regulation of T cell antigen processing and presentation(GO:0002625) positive regulation of iron ion transport(GO:0034758) positive regulation of iron ion transmembrane transport(GO:0034761) regulation of iron ion import(GO:1900390) regulation of ferrous iron import into cell(GO:1903989) positive regulation of ferrous iron import into cell(GO:1903991) regulation of ferrous iron binding(GO:1904432) positive regulation of ferrous iron binding(GO:1904434) regulation of transferrin receptor binding(GO:1904435) positive regulation of transferrin receptor binding(GO:1904437) regulation of ferrous iron import across plasma membrane(GO:1904438) positive regulation of ferrous iron import across plasma membrane(GO:1904440) response to iron ion starvation(GO:1990641) |
| 0.3 | 1.1 | GO:1903998 | regulation of eating behavior(GO:1903998) |
| 0.3 | 4.3 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
| 0.3 | 0.8 | GO:0043396 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) regulation of G-protein coupled receptor internalization(GO:1904020) |
| 0.3 | 1.0 | GO:1904978 | regulation of endosome organization(GO:1904978) regulation of glucosylceramidase activity(GO:1905123) |
| 0.3 | 3.1 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.3 | 0.5 | GO:0060488 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 0.3 | 1.0 | GO:0032416 | negative regulation of sodium:proton antiporter activity(GO:0032416) |
| 0.3 | 3.3 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 0.3 | 0.8 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
| 0.2 | 6.6 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.2 | 1.5 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
| 0.2 | 1.0 | GO:0003335 | corneocyte development(GO:0003335) |
| 0.2 | 1.2 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
| 0.2 | 3.5 | GO:0042659 | spinal cord association neuron differentiation(GO:0021527) regulation of cell fate specification(GO:0042659) |
| 0.2 | 3.0 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
| 0.2 | 0.5 | GO:0015911 | plasma membrane long-chain fatty acid transport(GO:0015911) |
| 0.2 | 0.9 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 0.2 | 1.6 | GO:0071461 | cellular response to redox state(GO:0071461) |
| 0.2 | 2.1 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
| 0.2 | 1.9 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.2 | 1.3 | GO:1901910 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.2 | 1.0 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.2 | 1.2 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
| 0.2 | 2.4 | GO:0009414 | response to water deprivation(GO:0009414) |
| 0.2 | 1.2 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 0.2 | 1.0 | GO:0016036 | cellular response to phosphate starvation(GO:0016036) positive regulation of sulfur amino acid metabolic process(GO:0031337) positive regulation of homocysteine metabolic process(GO:0050668) |
| 0.2 | 1.9 | GO:0097350 | neutrophil clearance(GO:0097350) |
| 0.2 | 1.3 | GO:0016139 | glycoside catabolic process(GO:0016139) |
| 0.2 | 1.3 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 0.2 | 0.9 | GO:0072093 | metanephric renal vesicle formation(GO:0072093) |
| 0.2 | 3.3 | GO:0070914 | UV-damage excision repair(GO:0070914) |
| 0.2 | 0.4 | GO:0002232 | leukocyte chemotaxis involved in inflammatory response(GO:0002232) |
| 0.2 | 0.6 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 0.2 | 0.5 | GO:2000768 | positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
| 0.2 | 0.5 | GO:0032827 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) positive regulation of cytolysis in other organism(GO:0051714) |
| 0.2 | 0.5 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.2 | 1.4 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.2 | 1.6 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
| 0.2 | 1.2 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
| 0.2 | 0.7 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
| 0.2 | 0.7 | GO:1902617 | response to fluoride(GO:1902617) |
| 0.2 | 3.1 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
| 0.2 | 2.0 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
| 0.2 | 2.1 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
| 0.2 | 0.5 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 0.2 | 2.1 | GO:0015886 | heme transport(GO:0015886) |
| 0.2 | 0.9 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.2 | 0.5 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
| 0.2 | 1.8 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 0.2 | 0.3 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
| 0.1 | 2.4 | GO:0042711 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
| 0.1 | 0.6 | GO:0070124 | mitochondrial translational initiation(GO:0070124) |
| 0.1 | 2.9 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
| 0.1 | 0.4 | GO:0019858 | cytosine metabolic process(GO:0019858) |
| 0.1 | 1.4 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
| 0.1 | 1.1 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 0.1 | 2.0 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.1 | 2.5 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
| 0.1 | 0.4 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
| 0.1 | 1.8 | GO:0043589 | skin morphogenesis(GO:0043589) |
| 0.1 | 1.6 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.1 | 0.4 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
| 0.1 | 1.8 | GO:0008212 | mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
| 0.1 | 0.5 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.1 | 1.0 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.1 | 1.2 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.1 | 0.5 | GO:0015917 | aminophospholipid transport(GO:0015917) |
| 0.1 | 0.8 | GO:0048014 | Tie signaling pathway(GO:0048014) |
| 0.1 | 0.5 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
| 0.1 | 0.7 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 | 2.1 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
| 0.1 | 2.1 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
| 0.1 | 1.0 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.1 | 0.4 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
| 0.1 | 0.3 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
| 0.1 | 0.2 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
| 0.1 | 0.8 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.1 | 0.5 | GO:0061205 | alveolar primary septum development(GO:0061143) paramesonephric duct development(GO:0061205) |
| 0.1 | 0.8 | GO:0051599 | response to water(GO:0009415) response to hydrostatic pressure(GO:0051599) |
| 0.1 | 0.2 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
| 0.1 | 1.4 | GO:1990035 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.1 | 0.9 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.1 | 0.6 | GO:1902996 | macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) regulation of neurofibrillary tangle assembly(GO:1902996) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
| 0.1 | 0.4 | GO:0046373 | arabinose metabolic process(GO:0019566) L-arabinose metabolic process(GO:0046373) |
| 0.1 | 1.1 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.1 | 0.3 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
| 0.1 | 2.0 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
| 0.1 | 1.2 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
| 0.1 | 0.9 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.1 | 0.5 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
| 0.1 | 0.2 | GO:0071314 | regulation of corticotropin secretion(GO:0051459) cellular response to cocaine(GO:0071314) |
| 0.1 | 0.9 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
| 0.1 | 0.4 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.1 | 1.6 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
| 0.1 | 1.4 | GO:1904886 | beta-catenin destruction complex disassembly(GO:1904886) |
| 0.1 | 0.3 | GO:1900248 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
| 0.1 | 0.4 | GO:2000035 | regulation of stem cell division(GO:2000035) |
| 0.1 | 0.7 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
| 0.1 | 0.7 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
| 0.1 | 0.8 | GO:0042426 | choline catabolic process(GO:0042426) |
| 0.1 | 0.3 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
| 0.1 | 0.9 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
| 0.1 | 0.3 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
| 0.1 | 0.2 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
| 0.1 | 0.9 | GO:0016584 | nucleosome positioning(GO:0016584) |
| 0.1 | 0.5 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
| 0.1 | 0.4 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.1 | 0.9 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.1 | 0.4 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
| 0.1 | 0.3 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.1 | 0.5 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.1 | 0.3 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.1 | 0.4 | GO:0035754 | B cell chemotaxis(GO:0035754) |
| 0.1 | 1.0 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.1 | 0.2 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
| 0.1 | 1.7 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.1 | 0.6 | GO:0003096 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 0.1 | 0.4 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
| 0.1 | 0.6 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 0.1 | 0.1 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
| 0.1 | 0.4 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.1 | 0.6 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.1 | 0.7 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
| 0.1 | 0.6 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) neural plate regionalization(GO:0060897) |
| 0.1 | 0.1 | GO:0090034 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 0.1 | 0.6 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) |
| 0.1 | 2.5 | GO:0006198 | cAMP catabolic process(GO:0006198) |
| 0.1 | 1.0 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.1 | 0.9 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.1 | 0.3 | GO:0015798 | myo-inositol transport(GO:0015798) |
| 0.1 | 0.6 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
| 0.1 | 0.4 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.1 | 0.4 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
| 0.1 | 6.9 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
| 0.1 | 1.3 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
| 0.1 | 0.4 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.1 | 0.2 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.1 | 0.4 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.1 | 0.2 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
| 0.1 | 0.9 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
| 0.1 | 0.6 | GO:1903672 | positive regulation of sprouting angiogenesis(GO:1903672) |
| 0.1 | 0.6 | GO:0033227 | dsRNA transport(GO:0033227) |
| 0.1 | 0.4 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.0 | 1.4 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
| 0.0 | 0.8 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
| 0.0 | 0.2 | GO:0015862 | uridine transport(GO:0015862) |
| 0.0 | 0.3 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
| 0.0 | 0.6 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 0.0 | 0.1 | GO:0002894 | positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
| 0.0 | 0.3 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.0 | 0.4 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.0 | 0.5 | GO:2000580 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.0 | 0.2 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
| 0.0 | 0.6 | GO:0035826 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 0.0 | 1.8 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
| 0.0 | 0.9 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.0 | 0.2 | GO:1990418 | response to sodium phosphate(GO:1904383) response to insulin-like growth factor stimulus(GO:1990418) |
| 0.0 | 0.9 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.0 | 0.3 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.0 | 1.3 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 0.0 | 0.2 | GO:1901660 | calcium ion export(GO:1901660) calcium ion export from cell(GO:1990034) |
| 0.0 | 0.3 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
| 0.0 | 0.9 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.0 | 11.0 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
| 0.0 | 0.2 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
| 0.0 | 7.4 | GO:0031424 | keratinization(GO:0031424) |
| 0.0 | 0.3 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
| 0.0 | 0.3 | GO:0070055 | mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) peptidyl-serine autophosphorylation(GO:0036289) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
| 0.0 | 0.3 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
| 0.0 | 0.3 | GO:0097491 | sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
| 0.0 | 0.1 | GO:0021539 | subthalamus development(GO:0021539) |
| 0.0 | 0.5 | GO:0035878 | ectodermal cell differentiation(GO:0010668) nail development(GO:0035878) |
| 0.0 | 0.2 | GO:0045991 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) carbon catabolite activation of transcription(GO:0045991) positive regulation of transcription by glucose(GO:0046016) |
| 0.0 | 0.5 | GO:0007220 | Notch receptor processing(GO:0007220) |
| 0.0 | 7.4 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
| 0.0 | 0.1 | GO:0032455 | nerve growth factor processing(GO:0032455) |
| 0.0 | 0.7 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.0 | 0.5 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
| 0.0 | 0.2 | GO:0006600 | creatine metabolic process(GO:0006600) |
| 0.0 | 0.3 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
| 0.0 | 0.2 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.0 | 0.1 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
| 0.0 | 0.1 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) |
| 0.0 | 0.4 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.0 | 0.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
| 0.0 | 0.1 | GO:1903423 | positive regulation of synaptic vesicle endocytosis(GO:1900244) positive regulation of synaptic vesicle transport(GO:1902805) positive regulation of synaptic vesicle recycling(GO:1903423) |
| 0.0 | 0.4 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.0 | 0.5 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
| 0.0 | 0.2 | GO:0070459 | prolactin secretion(GO:0070459) |
| 0.0 | 0.8 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.0 | 0.2 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.0 | 0.3 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 0.0 | 0.3 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 0.0 | 0.5 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.0 | 1.5 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
| 0.0 | 0.3 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
| 0.0 | 0.1 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
| 0.0 | 0.2 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.0 | 0.1 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 0.0 | 0.5 | GO:0015671 | oxygen transport(GO:0015671) |
| 0.0 | 0.1 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.0 | 0.2 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.0 | 0.1 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
| 0.0 | 0.6 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.0 | 0.2 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
| 0.0 | 0.6 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
| 0.0 | 0.1 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.0 | 0.2 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
| 0.0 | 0.2 | GO:0032025 | response to cobalt ion(GO:0032025) |
| 0.0 | 0.3 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.0 | 0.1 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
| 0.0 | 0.5 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
| 0.0 | 0.2 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
| 0.0 | 0.1 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.0 | 2.3 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
| 0.0 | 1.6 | GO:0043967 | histone H4 acetylation(GO:0043967) |
| 0.0 | 0.6 | GO:0044458 | motile cilium assembly(GO:0044458) |
| 0.0 | 0.3 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
| 0.0 | 0.8 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.0 | 1.0 | GO:0009301 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.0 | 1.9 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
| 0.0 | 0.5 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
| 0.0 | 0.2 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
| 0.0 | 0.4 | GO:0021511 | spinal cord patterning(GO:0021511) |
| 0.0 | 0.3 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
| 0.0 | 0.6 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
| 0.0 | 0.7 | GO:0006308 | DNA catabolic process(GO:0006308) |
| 0.0 | 0.0 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
| 0.0 | 0.2 | GO:0021924 | cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
| 0.0 | 0.1 | GO:0048203 | vesicle targeting, trans-Golgi to endosome(GO:0048203) |
| 0.0 | 1.0 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
| 0.0 | 0.6 | GO:0043304 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
| 0.0 | 0.7 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
| 0.0 | 0.2 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.0 | 0.2 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 0.0 | 0.1 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 0.0 | 0.4 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.0 | 0.3 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.0 | 0.3 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 0.0 | 1.3 | GO:0001895 | retina homeostasis(GO:0001895) |
| 0.0 | 0.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 0.0 | 0.1 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.0 | 0.3 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.0 | 0.2 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 0.0 | 0.3 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) |
| 0.0 | 0.1 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.0 | 0.9 | GO:1903318 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
| 0.0 | 0.2 | GO:0030575 | nuclear body organization(GO:0030575) |
| 0.0 | 0.4 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
| 0.0 | 0.2 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.0 | 0.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 0.0 | 0.5 | GO:0045921 | positive regulation of exocytosis(GO:0045921) |
| 0.0 | 0.6 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
| 0.0 | 0.2 | GO:0031063 | regulation of histone deacetylation(GO:0031063) |
| 0.0 | 1.8 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.0 | 0.5 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
| 0.0 | 2.9 | GO:0031032 | actomyosin structure organization(GO:0031032) |
| 0.0 | 0.6 | GO:0031640 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
| 0.0 | 0.2 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
| 0.0 | 0.1 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
| 0.0 | 0.2 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.0 | 0.0 | GO:2000542 | regulation of endodermal cell differentiation(GO:1903224) negative regulation of endodermal cell differentiation(GO:1903225) negative regulation of gastrulation(GO:2000542) |
| 0.0 | 0.6 | GO:0001824 | blastocyst development(GO:0001824) |
| 0.0 | 0.5 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.0 | 0.2 | GO:0034142 | toll-like receptor 4 signaling pathway(GO:0034142) |
| 0.0 | 0.9 | GO:0030183 | B cell differentiation(GO:0030183) |
| 0.0 | 0.2 | GO:0071711 | basement membrane organization(GO:0071711) |
| 0.0 | 0.3 | GO:0051932 | synaptic transmission, GABAergic(GO:0051932) |
| 0.0 | 0.2 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.0 | 0.4 | GO:0090383 | phagosome acidification(GO:0090383) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.0 | 4.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
| 0.5 | 1.6 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
| 0.5 | 1.6 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 0.5 | 2.5 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
| 0.5 | 1.4 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
| 0.4 | 3.3 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.4 | 2.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 0.3 | 2.5 | GO:0005955 | calcineurin complex(GO:0005955) |
| 0.3 | 0.8 | GO:0034680 | integrin alpha10-beta1 complex(GO:0034680) |
| 0.2 | 6.5 | GO:0010369 | chromocenter(GO:0010369) |
| 0.2 | 1.8 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.2 | 1.5 | GO:1990393 | 3M complex(GO:1990393) |
| 0.2 | 0.2 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
| 0.2 | 1.3 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
| 0.2 | 1.2 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
| 0.2 | 2.3 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 0.2 | 1.9 | GO:0016011 | dystroglycan complex(GO:0016011) |
| 0.2 | 0.5 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
| 0.2 | 2.2 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
| 0.2 | 0.6 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
| 0.1 | 0.5 | GO:0031213 | RSF complex(GO:0031213) |
| 0.1 | 0.8 | GO:1990357 | terminal web(GO:1990357) |
| 0.1 | 0.3 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) PCSK9-AnxA2 complex(GO:1990667) |
| 0.1 | 0.8 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.1 | 0.4 | GO:0097224 | sperm connecting piece(GO:0097224) |
| 0.1 | 0.3 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
| 0.1 | 0.5 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.1 | 1.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.1 | 1.9 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
| 0.1 | 0.6 | GO:0033263 | CORVET complex(GO:0033263) |
| 0.1 | 0.7 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
| 0.1 | 1.0 | GO:0031906 | late endosome lumen(GO:0031906) |
| 0.1 | 7.1 | GO:0045095 | keratin filament(GO:0045095) |
| 0.1 | 0.6 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 0.1 | 0.8 | GO:0016342 | catenin complex(GO:0016342) |
| 0.1 | 2.4 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.1 | 0.8 | GO:0071953 | elastic fiber(GO:0071953) |
| 0.1 | 4.3 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
| 0.1 | 3.3 | GO:0005605 | basal lamina(GO:0005605) |
| 0.1 | 0.5 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
| 0.1 | 0.3 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.1 | 0.3 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.1 | 1.8 | GO:0071565 | nBAF complex(GO:0071565) |
| 0.1 | 0.2 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
| 0.1 | 1.1 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.1 | 0.2 | GO:0018444 | translation release factor complex(GO:0018444) |
| 0.1 | 1.3 | GO:0044232 | organelle membrane contact site(GO:0044232) |
| 0.1 | 0.3 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
| 0.1 | 0.8 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.1 | 29.1 | GO:0005667 | transcription factor complex(GO:0005667) |
| 0.1 | 0.6 | GO:0042583 | chromaffin granule(GO:0042583) |
| 0.1 | 2.7 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
| 0.0 | 0.4 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 0.0 | 0.2 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 0.0 | 0.2 | GO:0098536 | deuterosome(GO:0098536) |
| 0.0 | 0.5 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
| 0.0 | 0.6 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
| 0.0 | 4.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.0 | 2.6 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.0 | 0.5 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
| 0.0 | 0.1 | GO:0032280 | symmetric synapse(GO:0032280) |
| 0.0 | 0.7 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.0 | 0.1 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 0.0 | 0.6 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.0 | 0.1 | GO:0032437 | cuticular plate(GO:0032437) |
| 0.0 | 5.4 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 0.0 | 0.3 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
| 0.0 | 2.0 | GO:0097542 | ciliary tip(GO:0097542) |
| 0.0 | 1.1 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.0 | 0.3 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
| 0.0 | 0.4 | GO:0031045 | dense core granule(GO:0031045) |
| 0.0 | 2.1 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.0 | 3.5 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
| 0.0 | 4.6 | GO:0005814 | centriole(GO:0005814) |
| 0.0 | 2.4 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.0 | 0.8 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
| 0.0 | 11.6 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.0 | 0.6 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.0 | 0.5 | GO:0000812 | Swr1 complex(GO:0000812) |
| 0.0 | 0.3 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
| 0.0 | 1.0 | GO:0000145 | exocyst(GO:0000145) |
| 0.0 | 1.6 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.0 | 0.5 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.0 | 2.5 | GO:0045178 | basal part of cell(GO:0045178) |
| 0.0 | 1.1 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
| 0.0 | 0.9 | GO:0005640 | nuclear outer membrane(GO:0005640) |
| 0.0 | 0.1 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 0.0 | 4.0 | GO:0005795 | Golgi stack(GO:0005795) |
| 0.0 | 1.2 | GO:0060170 | ciliary membrane(GO:0060170) |
| 0.0 | 0.5 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 0.0 | 0.1 | GO:0005883 | neurofilament(GO:0005883) |
| 0.0 | 0.3 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 0.0 | 0.9 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 0.0 | 0.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.0 | 0.1 | GO:0045257 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 0.0 | 0.3 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.0 | 0.1 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 0.0 | 0.1 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 0.0 | 0.4 | GO:0016592 | mediator complex(GO:0016592) |
| 0.0 | 0.1 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.0 | 0.2 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.0 | 1.3 | GO:0043195 | terminal bouton(GO:0043195) |
| 0.0 | 0.7 | GO:0031201 | SNARE complex(GO:0031201) |
| 0.0 | 0.9 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
| 0.0 | 1.8 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.0 | 0.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.0 | 0.8 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.0 | 0.2 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
| 0.0 | 0.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.0 | 2.6 | GO:0030018 | Z disc(GO:0030018) |
| 0.0 | 0.4 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
| 0.0 | 0.5 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.0 | 0.7 | GO:0036064 | ciliary basal body(GO:0036064) |
| 0.0 | 0.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.0 | 1.5 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
| 0.0 | 3.5 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
| 0.0 | 0.2 | GO:0030478 | actin cap(GO:0030478) |
| 0.0 | 0.3 | GO:0005861 | troponin complex(GO:0005861) |
| 0.0 | 0.6 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.0 | 0.3 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
| 0.0 | 0.2 | GO:0034451 | centriolar satellite(GO:0034451) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.1 | 3.3 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
| 0.9 | 16.0 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
| 0.8 | 10.1 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 0.8 | 10.0 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
| 0.7 | 2.9 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 0.7 | 2.1 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
| 0.6 | 3.1 | GO:0004359 | glutaminase activity(GO:0004359) |
| 0.6 | 1.7 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
| 0.5 | 1.6 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
| 0.5 | 2.5 | GO:0032810 | sterol response element binding(GO:0032810) |
| 0.5 | 2.0 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
| 0.4 | 1.3 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
| 0.4 | 3.9 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 0.4 | 1.3 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
| 0.4 | 2.5 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.4 | 1.9 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 0.4 | 1.9 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
| 0.4 | 4.0 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
| 0.3 | 0.3 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) |
| 0.3 | 2.1 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 0.3 | 2.8 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
| 0.3 | 0.8 | GO:0008969 | phosphohistidine phosphatase activity(GO:0008969) |
| 0.3 | 1.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 0.3 | 1.0 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 0.3 | 1.3 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
| 0.3 | 3.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.2 | 1.0 | GO:0032038 | myosin II heavy chain binding(GO:0032038) |
| 0.2 | 2.1 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
| 0.2 | 2.0 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.2 | 3.9 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
| 0.2 | 0.6 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
| 0.2 | 1.3 | GO:0052842 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
| 0.2 | 1.2 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
| 0.2 | 1.4 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
| 0.2 | 3.9 | GO:0015923 | mannosidase activity(GO:0015923) |
| 0.2 | 0.6 | GO:0031812 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
| 0.2 | 1.0 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.2 | 1.6 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
| 0.2 | 0.7 | GO:0038025 | reelin receptor activity(GO:0038025) |
| 0.2 | 2.9 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
| 0.2 | 0.5 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
| 0.2 | 1.0 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
| 0.2 | 2.7 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.2 | 1.0 | GO:0052796 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
| 0.2 | 8.0 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.2 | 1.4 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.2 | 1.2 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 0.1 | 1.0 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
| 0.1 | 1.0 | GO:0045159 | myosin II binding(GO:0045159) |
| 0.1 | 0.6 | GO:0051800 | phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity(GO:0051800) |
| 0.1 | 4.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.1 | 2.4 | GO:0004017 | adenylate kinase activity(GO:0004017) |
| 0.1 | 0.4 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
| 0.1 | 0.5 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
| 0.1 | 0.8 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
| 0.1 | 1.6 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 0.1 | 2.0 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 0.1 | 0.9 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
| 0.1 | 1.2 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
| 0.1 | 2.7 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.1 | 2.9 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
| 0.1 | 0.7 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
| 0.1 | 3.9 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
| 0.1 | 0.6 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
| 0.1 | 1.7 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
| 0.1 | 0.4 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
| 0.1 | 1.0 | GO:0043426 | MRF binding(GO:0043426) |
| 0.1 | 0.3 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
| 0.1 | 2.8 | GO:0005112 | Notch binding(GO:0005112) |
| 0.1 | 7.4 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
| 0.1 | 0.3 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.1 | 0.5 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.1 | 1.0 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
| 0.1 | 3.3 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 0.1 | 1.2 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.1 | 0.3 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 0.1 | 4.2 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.1 | 2.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.1 | 0.6 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.1 | 0.4 | GO:0046556 | alpha-L-arabinofuranosidase activity(GO:0046556) |
| 0.1 | 0.8 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
| 0.1 | 1.6 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
| 0.1 | 0.9 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
| 0.1 | 0.6 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
| 0.1 | 0.7 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 0.1 | 0.3 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
| 0.1 | 0.4 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
| 0.1 | 0.4 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
| 0.1 | 1.6 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
| 0.1 | 2.4 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.1 | 0.5 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
| 0.1 | 0.5 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 0.1 | 0.3 | GO:0004566 | beta-glucuronidase activity(GO:0004566) heparanase activity(GO:0030305) |
| 0.1 | 0.3 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
| 0.1 | 0.3 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
| 0.1 | 0.2 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
| 0.1 | 0.7 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 0.1 | 1.9 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
| 0.1 | 0.5 | GO:0032089 | NACHT domain binding(GO:0032089) |
| 0.1 | 0.7 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
| 0.1 | 0.1 | GO:1990763 | arrestin family protein binding(GO:1990763) |
| 0.1 | 0.4 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.1 | 0.4 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.1 | 2.0 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.1 | 0.3 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
| 0.1 | 0.3 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
| 0.1 | 0.8 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.1 | 0.5 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
| 0.1 | 1.6 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.1 | 0.3 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
| 0.1 | 2.5 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
| 0.1 | 0.4 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
| 0.1 | 0.4 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 0.1 | 8.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.1 | 5.0 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.1 | 0.4 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
| 0.1 | 0.3 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
| 0.1 | 0.9 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
| 0.1 | 0.2 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.1 | 1.2 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
| 0.1 | 1.5 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.1 | 2.3 | GO:0015248 | sterol transporter activity(GO:0015248) |
| 0.1 | 0.8 | GO:1990459 | transferrin receptor binding(GO:1990459) |
| 0.0 | 0.8 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.0 | 0.2 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
| 0.0 | 1.5 | GO:0016805 | dipeptidase activity(GO:0016805) |
| 0.0 | 0.9 | GO:0031404 | chloride ion binding(GO:0031404) |
| 0.0 | 0.7 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.0 | 0.4 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 0.0 | 0.4 | GO:0050693 | LBD domain binding(GO:0050693) |
| 0.0 | 1.9 | GO:0033613 | activating transcription factor binding(GO:0033613) |
| 0.0 | 0.9 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
| 0.0 | 0.9 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.0 | 3.4 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
| 0.0 | 0.6 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 0.0 | 0.3 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.0 | 1.1 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.0 | 0.3 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 0.0 | 0.5 | GO:0004985 | opioid receptor activity(GO:0004985) |
| 0.0 | 0.4 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.0 | 0.4 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
| 0.0 | 0.9 | GO:0001223 | transcription coactivator binding(GO:0001223) |
| 0.0 | 0.2 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 0.0 | 1.2 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.0 | 1.1 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
| 0.0 | 2.2 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
| 0.0 | 0.6 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.0 | 3.4 | GO:0003684 | damaged DNA binding(GO:0003684) |
| 0.0 | 0.5 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
| 0.0 | 0.1 | GO:0004961 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
| 0.0 | 0.2 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.0 | 0.4 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
| 0.0 | 0.1 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
| 0.0 | 0.4 | GO:0003993 | acid phosphatase activity(GO:0003993) |
| 0.0 | 0.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.0 | 0.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.0 | 2.8 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
| 0.0 | 1.5 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.0 | 1.3 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.0 | 0.3 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
| 0.0 | 0.5 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.0 | 1.3 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
| 0.0 | 0.5 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 0.0 | 0.3 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.0 | 1.0 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
| 0.0 | 0.5 | GO:0042805 | actinin binding(GO:0042805) |
| 0.0 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
| 0.0 | 0.6 | GO:0000339 | RNA cap binding(GO:0000339) |
| 0.0 | 1.8 | GO:0051287 | NAD binding(GO:0051287) |
| 0.0 | 0.2 | GO:1990254 | keratin filament binding(GO:1990254) |
| 0.0 | 1.7 | GO:0031491 | nucleosome binding(GO:0031491) |
| 0.0 | 0.1 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 0.0 | 0.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
| 0.0 | 0.4 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.0 | 0.2 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
| 0.0 | 0.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
| 0.0 | 0.5 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.0 | 0.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 0.0 | 0.9 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
| 0.0 | 0.1 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
| 0.0 | 0.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.0 | 0.1 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 0.0 | 0.1 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
| 0.0 | 0.2 | GO:0032027 | myosin light chain binding(GO:0032027) |
| 0.0 | 0.3 | GO:0005402 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
| 0.0 | 0.3 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
| 0.0 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
| 0.0 | 0.6 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.0 | 0.3 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
| 0.0 | 1.6 | GO:0030165 | PDZ domain binding(GO:0030165) |
| 0.0 | 0.4 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
| 0.0 | 0.1 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.0 | 0.2 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.0 | 0.6 | GO:0015144 | carbohydrate transmembrane transporter activity(GO:0015144) carbohydrate transporter activity(GO:1901476) |
| 0.0 | 0.9 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
| 0.0 | 0.0 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
| 0.0 | 0.1 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
| 0.0 | 0.1 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
| 0.0 | 0.4 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.0 | 0.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.0 | 0.5 | GO:0051183 | vitamin transporter activity(GO:0051183) |
| 0.0 | 0.1 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
| 0.0 | 0.3 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.0 | 0.1 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.0 | 1.0 | GO:0001618 | virus receptor activity(GO:0001618) |
| 0.0 | 0.2 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.2 | 2.7 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
| 0.1 | 7.2 | PID BMP PATHWAY | BMP receptor signaling |
| 0.1 | 1.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.1 | 2.4 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.1 | 9.7 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 0.1 | 4.4 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.1 | 3.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.1 | 4.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
| 0.1 | 5.7 | PID NOTCH PATHWAY | Notch signaling pathway |
| 0.1 | 1.8 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.1 | 4.4 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.1 | 3.7 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
| 0.1 | 2.3 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
| 0.1 | 4.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.1 | 3.9 | SIG CHEMOTAXIS | Genes related to chemotaxis |
| 0.1 | 3.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.1 | 0.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.0 | 1.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 0.0 | 1.1 | PID CD40 PATHWAY | CD40/CD40L signaling |
| 0.0 | 0.5 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 0.0 | 2.7 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.0 | 1.7 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.0 | 0.8 | ST GA13 PATHWAY | G alpha 13 Pathway |
| 0.0 | 0.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.0 | 2.9 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.0 | 0.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.0 | 0.1 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.0 | 3.5 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
| 0.0 | 1.5 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.0 | 1.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.0 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
| 0.0 | 1.0 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.0 | 0.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.0 | 0.5 | PID IGF1 PATHWAY | IGF1 pathway |
| 0.0 | 0.4 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
| 0.0 | 0.3 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.0 | 0.3 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.0 | 0.6 | PID CDC42 PATHWAY | CDC42 signaling events |
| 0.0 | 0.4 | PID P73PATHWAY | p73 transcription factor network |
| 0.0 | 0.6 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.4 | 5.0 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
| 0.2 | 6.1 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 0.2 | 9.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 0.2 | 1.8 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.1 | 1.6 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
| 0.1 | 2.9 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.1 | 5.0 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.1 | 1.8 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 0.1 | 3.1 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.1 | 1.6 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
| 0.1 | 3.7 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.1 | 4.3 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
| 0.1 | 4.2 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
| 0.1 | 3.2 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.1 | 1.3 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
| 0.1 | 0.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
| 0.1 | 0.6 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 0.1 | 0.5 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 0.1 | 2.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.1 | 1.7 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.1 | 7.3 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.1 | 2.5 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.1 | 2.1 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.1 | 5.2 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.1 | 1.3 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.1 | 2.1 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
| 0.1 | 0.9 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
| 0.1 | 2.3 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.0 | 0.6 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.0 | 2.0 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
| 0.0 | 1.3 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
| 0.0 | 0.2 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.0 | 0.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.0 | 0.8 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.0 | 0.3 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
| 0.0 | 0.4 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.0 | 1.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.0 | 0.1 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
| 0.0 | 1.6 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
| 0.0 | 0.9 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
| 0.0 | 1.6 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.0 | 1.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.0 | 0.6 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
| 0.0 | 0.6 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
| 0.0 | 2.6 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
| 0.0 | 0.4 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.0 | 4.6 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
| 0.0 | 1.2 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.0 | 0.7 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.0 | 1.2 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
| 0.0 | 1.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 0.0 | 0.7 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.0 | 0.4 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
| 0.0 | 0.2 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.0 | 0.1 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
| 0.0 | 0.8 | REACTOME KINESINS | Genes involved in Kinesins |
| 0.0 | 1.4 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.0 | 1.8 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.0 | 0.8 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.0 | 1.1 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
| 0.0 | 0.7 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.0 | 0.5 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
| 0.0 | 0.6 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.0 | 0.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.0 | 0.7 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
| 0.0 | 2.5 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.0 | 1.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
| 0.0 | 0.3 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.0 | 0.3 | REACTOME BIOLOGICAL OXIDATIONS | Genes involved in Biological oxidations |
| 0.0 | 0.2 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 0.0 | 0.2 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.0 | 0.3 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
| 0.0 | 0.2 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
| 0.0 | 0.4 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
| 0.0 | 0.4 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
| 0.0 | 0.4 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.0 | 0.8 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
| 0.0 | 0.4 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.0 | 0.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |